Page 37 - Sanket Koul

Indian population saw 30% increase in ANAs post Covid-19, says study

ANAs are proteins produced by the immune system that mistakenly target the body's own cells, leading to tissue damage and autoimmune diseases like rheumatoid arthritis and thyroid disorders

NOTTO urges states, UTs to act against eye banks not meeting targets

The step comes as NOTTO looks to link all cornea transplant centres and tissue banks, including eye banks, with a national registry database of patients maintained by it

Indian CDMOs could account for up to 10% of global outsourced work by 2033

The survey states that the industry is about to witness a redistribution of outsourcing work across several Asian countries, with India and Korea emerging as new powerhouses by 2033

NPPA raises ceiling prices of 8 scheduled drugs for asthma, TB, glaucoma

Ceiling prices were also revised for the asthma drug Salbutamol in tablets of 2 mg and 4 mg formulations and respirator solution of 5 mg/ml formulation

Faima pauses strike as Bengal govt holds emergency meet with doctors

Doctor's body asks resident doctors associations to be ready to stop elective services in case meeting does not address demands

Southern states dominate authorised hospital admissions under PMJAY

TN, Kerala among top five despite gradual fall in hospital admissions in the last three years

Faima calls for elective services shutdown in hospitals from Monday

Several RDAs and other doctors' associations across India had earlier shut non-urgent elective services for 13 days in August 2024, calling it off after being urged by the Supreme Court

Indian pharma market registers over 5% growth in Sept 2024: Pharmarack

This comes even as the IPM registered a negative unit growth of -2.3 per cent, with only anti-diabetic and urology therapy segments recording significant unit growth of 3.1 per cent and 5.4 per cent

CDSCO plans to ask more brands to put QR codes on packaging to stop fakes

This follows CDSCO's move last year to strictly implement barcodes or QR codes on 300 top medicine brands such as Allegra, Calpol, and Dolo

Govt approves Rs 1,040 crore boost for TB patient nutritional support

It was also decided to introduce energy-dense nutrition supplementation (EDNS) for all underweight TB patients or those with a body mass index (BMI) less than 18.5 kg/m² at the time of diagnosis

US FDA grants fast track status to Wockhardt's novel antibiotic WCK 6777

WCK 6777 is a once-a-day, β-lactam enhancer used for outpatient parenteral antimicrobial therapy

Indian education sector needs to prepare itself for AI-driven future

The second of a three-part series reports on how education institutes are addressing the skills shortage

Karnataka tops in verified health facility registry; TN, Odisha at bottom

Low saturation rates delaying HFR process: Officials

Draft norms on passive euthanasia can expose doctors to legal scrutiny

Bold step, but doctors may be concerned over increased legal scrutiny, say experts

Draft norms on passive euthanasia can expose doctors to legal scrutiny: IMA

National President IMA R V Asokan says doctors have always taken such clinical decisions in good faith

After Torrent, Alkem refutes claims of its drugs failing CDSCO test

Company claims samples of Pan-D, Clavam 625 tested were spurious, not manufactured by it

Govt issues new advisory to states, UTs after first Mpox Clade 1b case

The advisory asks states and UTs to continue undertaking appropriate activities to make communities aware of the disease, its modes of spread, and the need for timely reporting and preventive measures

Torrent Pharmaceuticals refutes claim of Shelcal 500 failing CDSCO test

Company claims sample tested was spurious and not manufactured by it

Entod Pharma meets DCGI, issues clarification over eye drop 'claims'

Move comes after drug regulator had suspended nod granted to firm to manufacture, sell PresVu eye drops

Out-of-pocket health spend falls, govt spend rises in NHA 2021-22

According to the estimates, the coverage of private health insurance also showed an upward trend, rising from 5.8 per cent in 2017-18 to 7.4 per cent in 2021-22